APA (7th ed.) Citation

Lobzin, Y. V., Zhdanov, K. V., Simbirtsev, A. S., Yakovlev, A. A., Kizhlo, S. N., Fazilov, V. H., . . . Lebedev, M. F. Efficacy and safety of triple therapy with recombinant interleukin-1β, recombinant interferon-α and ribavirin in patients with chronic hepatitis C, genotype 1 infection, the non-responders to previous treatment with interferon and ribavirin. Journal Infectology.

Chicago Style (17th ed.) Citation

Lobzin, Yu. V., K. V. Zhdanov, A. S. Simbirtsev, A. A. Yakovlev, S. N. Kizhlo, V. H. Fazilov, S. N. Zharov, and M. F. Lebedev. Efficacy and Safety of Triple Therapy with Recombinant Interleukin-1β, Recombinant Interferon-α and Ribavirin in Patients with Chronic Hepatitis C, Genotype 1 Infection, the Non-responders to Previous Treatment with Interferon and Ribavirin. Journal Infectology.

MLA (9th ed.) Citation

Lobzin, Yu. V., et al. Efficacy and Safety of Triple Therapy with Recombinant Interleukin-1β, Recombinant Interferon-α and Ribavirin in Patients with Chronic Hepatitis C, Genotype 1 Infection, the Non-responders to Previous Treatment with Interferon and Ribavirin. Journal Infectology.